These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11960640)

  • 1. Role of IL-5 during primary and secondary immune response to acetylcholine receptor.
    Poussin MA; Goluszko E; Franco JU; Christadoss P
    J Neuroimmunol; 2002 Apr; 125(1-2):51-8. PubMed ID: 11960640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of experimental autoimmune myasthenia gravis in IL-10 gene-disrupted mice is associated with reduced B cells and serum cytotoxicity on mouse cell line expressing AChR.
    Poussin MA; Goluszko E; Hughes TK; Duchicella SI; Christadoss P
    J Neuroimmunol; 2000 Nov; 111(1-2):152-60. PubMed ID: 11063833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production.
    Deng C; Goluszko E; Tüzün E; Yang H; Christadoss P
    J Immunol; 2002 Jul; 169(2):1077-83. PubMed ID: 12097416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice.
    Balasa B; Deng C; Lee J; Bradley LM; Dalton DK; Christadoss P; Sarvetnick N
    J Exp Med; 1997 Aug; 186(3):385-91. PubMed ID: 9236190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis.
    Zhang GX; Xiao BG; Bai XF; van der Meide PH; Orn A; Link H
    J Immunol; 1999 Apr; 162(7):3775-81. PubMed ID: 10201893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice.
    Ulusoy C; Çavuş F; Yılmaz V; Tüzün E
    Immunol Invest; 2017 Jul; 46(5):490-499. PubMed ID: 28375749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis.
    Balasa B; Deng C; Lee J; Christadoss P; Sarvetnick N
    J Immunol; 1998 Sep; 161(6):2856-62. PubMed ID: 9743346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice.
    Karachunski PI; Ostlie NS; Monfardini C; Conti-Fine BM
    J Immunol; 2000 May; 164(10):5236-44. PubMed ID: 10799884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of the IL-1beta gene diminishes acetylcholine receptor-induced immune responses in a murine model of myasthenia gravis.
    Huang D; Shi FD; Giscombe R; Zhou Y; Ljunggren HG; Lefvert AK
    Eur J Immunol; 2001 Jan; 31(1):225-32. PubMed ID: 11265638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-gamma-expressing Th1-like cells and up-regulation of TGF-beta mRNA in mononuclear cells.
    Ma CG; Zhang GX; Xiao BG; Wang ZY; Link J; Olsson T; Link H
    Ann N Y Acad Sci; 1996 Feb; 778():273-87. PubMed ID: 8610980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis.
    Ostlie NS; Karachunski PI; Wang W; Monfardini C; Kronenberg M; Conti-Fine BM
    J Immunol; 2001 Apr; 166(8):4853-62. PubMed ID: 11290761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of B cell deficiency on the immune response to acetylcholine receptor and the development of experimental autoimmune myasthenia gravis.
    Dedhia V; Goluszko E; Wu B; Deng C; Christadoss P
    Clin Immunol Immunopathol; 1998 Jun; 87(3):266-75. PubMed ID: 9646836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular immune response to acetylcholine receptors in murine experimental autoimmune myasthenia gravis: inhibition with monoclonal anti-I-A antibodies.
    Christadoss P; Lindstrom J; Talal N
    Cell Immunol; 1983 Oct; 81(1):1-8. PubMed ID: 6577968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1 receptor antagonist-mediated therapeutic effect in murine myasthenia gravis is associated with suppressed serum proinflammatory cytokines, C3, and anti-acetylcholine receptor IgG1.
    Yang H; Tüzün E; Alagappan D; Yu X; Scott BG; Ischenko A; Christadoss P
    J Immunol; 2005 Aug; 175(3):2018-25. PubMed ID: 16034147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models of myasthenia gravis.
    Christadoss P; Poussin M; Deng C
    Clin Immunol; 2000 Feb; 94(2):75-87. PubMed ID: 10637092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-12 enhances clinical experimental autoimmune myasthenia gravis in susceptible but not resistant mice.
    Sitaraman S; Metzger DW; Belloto RJ; Infante AJ; Wall KA
    J Neuroimmunol; 2000 Jul; 107(1):73-82. PubMed ID: 10808053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile of the regions of acetylcholine receptor alpha chain recognized by T-lymphocytes and by antibodies in EAMG-susceptible and non-susceptible mouse strains after different periods of immunization with the receptor.
    Oshima M; Pachner AR; Atassi MZ
    Mol Immunol; 1994 Aug; 31(11):833-43. PubMed ID: 7519305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CTLA-4 antibody treatment triggers determinant spreading and enhances murine myasthenia gravis.
    Wang HB; Shi FD; Li H; Chambers BJ; Link H; Ljunggren HG
    J Immunol; 2001 May; 166(10):6430-6. PubMed ID: 11342669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptor.
    Shenoy M; Oshima M; Atassi MZ; Christadoss P
    Clin Immunol Immunopathol; 1993 Mar; 66(3):230-8. PubMed ID: 7679342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressed clinical experimental autoimmune myasthenia gravis in bm12 mice is linked to reduced intracellular calcium mobilization and IL-10 and IFN-gamma release by acetylcholine receptor-specific T cells.
    Poussin MA; Fuller CL; Goluszko E; Reyes VE; Braciale VL; Christadoss P
    J Neuroimmunol; 2003 Jan; 134(1-2):104-10. PubMed ID: 12507777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.